Filtros de búsqueda

Lista de obras de

A new standard of care for patients with surgically unresectable stage III non-small cell lung cancer

scientific article published on 02 March 2019

Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials

artículo científico publicado en 2019

Comparison of the toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer: A systematic analysis of the literature

artículo científico publicado en 2017

Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

artículo científico

Comprehensive Characterization of Cancer Driver Genes and Mutations

article

Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base

artículo científico publicado en 2017

ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib

artículo científico publicado en 2019

Efficacy and safety of immune checkpoint blockade in self-identified black patients with advanced non-small cell lung cancer

artículo científico publicado en 2020

Epidermal growth factor receptor mutation analysis in tissue and plasma from the AURA3 trial: Osimertinib versus platinum-pemetrexed for T790M mutation-positive advanced non-small cell lung cancer

artículo científico publicado en 2019

HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium.

artículo científico publicado en 2017

Health care disparities among octogenarians and nonagenarians with stage III lung cancer

artículo científico publicado en 2018

Immune checkpoint inhibitors in advanced non-small cell lung cancer

artículo científico publicado en 2017

Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.

artículo científico publicado en 2015

MEK or ERK inhibition effectively abrogates emergence of acquired osimertinib resistance in the treatment of epidermal growth factor receptor-mutant lung cancers

artículo científico publicado en 2020

Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.

artículo científico publicado en 2017

Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-term follow-up from a pooled analysis of 2 phase 2 studies

scientific article published on 04 December 2018

Overcoming acquired resistance of epidermal growth factor receptor-mutant non-small cell lung cancer cells to osimertinib by combining osimertinib with the histone deacetylase inhibitor panobinostat (LBH589)

scientific article published on 30 January 2020

Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q

artículo científico publicado en 2020

Scientific Advances in Lung Cancer 2015.

artículo científico publicado en 2016

Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy

scientific article published on 18 August 2018

Targeting KRAS-Mutant Non-Small-Cell Lung Cancer: One Mutation at a Time, With a Focus on KRAS G12C Mutations

artículo científico publicado en 2020

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda